Prime Medicine (PRME) Other Non Operating Income (2021 - 2026)
Prime Medicine (PRME) reported Other Non Operating Income of $51000.0 for Q1 2026, up 37.84% on a YoY basis from $37000.0 in Q1 2025, and up 4.08% quarter-over-quarter from $49000.0 in Q4 2025.
Prime Medicine (PRME) Other Non Operating Income (2021 - 2026) Analysis & Trends
Prime Medicine has reported Other Non Operating Income for 6 years, with the latest figure at $51000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 37.84% year-over-year to $51000.0; the trailing twelve-month figure through Mar 2026 stood at $162000.0 (up 350.0% YoY), and the FY2025 full-year result was $148000.0, up 260.98% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $51000.0, up from $49000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $2.1 million in Q1 2023, with the low at -$83000.0 in Q3 2024.
- Historically, Other Non Operating Income has averaged $265294.1 across 5 years, with a median of $43000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Non Operating Income soared 72900.0% — and 2024, when it tumbled 293.02%.
- Prime Medicine's Other Non Operating Income stood at $926000.0 in 2022, then plunged by 84.02% to $148000.0 in 2023, then sank by 70.95% to $43000.0 in 2024, then grew by 13.95% to $49000.0 in 2025, then advanced by 4.08% to $51000.0 in 2026.
- The last three Other Non Operating Income figures came in at $51000.0 (Q1 2026), $49000.0 (Q4 2025), and $44000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prime Medicine | 572.02 Mn | 572.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 148,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 926,000.00 |
| Sep 30, 2022 | 728,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | -1,000.00 |